Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
AstraZeneca
Colorcon
Mallinckrodt
Dow

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: flurazepam hydrochloride

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

FLURAZEPAM

CASRN: 17617-23-1

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Mallinckrodt
Dow
AstraZeneca